Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro

Veterinary Therapeutics

Volumn 3, Issue 4, 2002, Pages

  Gibbs, Penelope ^a   Wooley, Richard ^a   Brothers, Amy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ENTEROCOCCUS; ESCHERICHIA COLI; KLEBSIELLA; PROTEUS (ENTEROBACTERIA); PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS;

EID: 79251500033     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mengozzi G, Intorre L, Bertini S, et al: Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep. Am J Vet Res 57:1040-1043, 1996.
2. Walker RD: Antimicrobial Therapy in Veterinary Medicine, ed 3. Ames, Iowa State University Press, 2000, pp 322-326.
3. Hooper DC, Wolfson JS: Quinolone Antimicrobial Agents, ed 2. Washington DC, American Society for Microbiology, 1993, pp 53-76, 97-118.
4. Reece RJ, Maxwell A: DNA gyrase: Structure and function. Crit Rev Biochem Mol Biol 26:335-375, 1991.
5. Sanzey B: Modulation of gene expression by drugs affecting deoxyribonucleic acid gyrase. J Bacteriol 138:40-47, 1979.
6. Smith GR: DNA super coiling: Another level for regulating gene expression. Cell 24:599-600, 1981.
7. Vosberg HP: DNA topoisomerase: Enzymes that control DNA conformation. Curr Topics Microbiol Immunol 114:19-101, 1985.
8. Brown JC, Amyes SGB: Quinolone resistance, in Woodward N, Johnson AP (eds): Molecular Bacteriology. Totowa, NJ, Humana Press, 1998, pp 617-639.
9. Park YH, Yoo JH, Huh DH, et al: Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes. Yonsei Med J 39:534-540, 1998.
10. Tavio M, Vila J, Ruiz J, et al: Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother 44:735-742, 1999.
11. Cooke CL, Singer RA, Jang SS, et al: Enrofloxacin resistance in Escherichia coli isolated form dogs with urinary tract infections. JAVMA 220:190-192, 2002.
12. Linde HJ, Notka F, Metz M, et al: In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR. Antimicrob Agents Chemother 44:1965-1968, 2000.
13. Cohen SP, McMurry LM, Hooper DC, et al: Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: Decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 33:1318-1325, 1989.
14. Prescott JF: Antimicrobial drug resistance and its epidemiology, in Prescott JF, Baggot JD, Walker RD (eds): Antimicrobial Therapy in Veterinary Medicine. Ames, Iowa State University Press, 2000, pp 27.
15. NCCLS: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria from Animals; Approved Standard (M31-A). Villanova, PA, National Committee for Clinical Laboratory Standards, 1999.
16. Medders WM, Wooley RE, Gibbs PS, et al: Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones. Avian Dis 42:146-153, 1998.
17. Kung K, Riond LJ, Wanner M: Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther 16:462-468, 1993.
18. Martin Barrasa JL, Lupiola Gomez P, Gonzalez Lama Z, et al: Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic otitis externa. J Vet Med B Infect Dis Vet Public Health 47:191-196, 2000.
19. Zhanel GG, Karlowsky JA, Saunders MH, et al: Development of multiple antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones. Antimicrob Agents Chemother 39:489-495, 1995.
20. Cole LK, Kwochka KW, Kowalski JJ, et al: Microbial flora and antimicrobial susceptibility patterns of isolated pathogens from the horizontal ear canal and middle ear in dogs with otitis media. JAVMA 212:534-538, 1998.